Merck & Co/MSD has won approval in the US for PD-1 inhibitor Keytruda as a treatment for hepatocellular carcinoma (HCC), the most common form of liver cancer, opening up another front in its ...

The Chinese contract drugmaker will sell its vaccine factory in Dundalk, Ireland, to U.S.-based Merck for about $500 million, it said in an exchange filing late Monday. The facility, with a net ...

Last Friday, the Medicines and Healthcare Products Regulatory Agency approved Merck & Co Inc’s (NYSE:MRK) Winrevair (sotatercept) for adult patients with pulmonary arterial hypertension (PAH).

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Gardasil has recently seen slumping sales in China, where it's being marketed by Merck’s regional commercial partner Zhifei Biological Products. Rob David previously called the expansion to the ...

It follows 24-week results reported earlier this year and means that the new regimen will now advance into a phase 3 programme, said Gilead and MSD, known as Merck & Co in the US and Canada.

Kovalenko scored a goal Saturday in a 3-2 win over New Jersey. Kovalenko's goal was his first for San Jose since being acquired from Colorado on Dec. 9. He drove the net and fired low through ...

Merck wins UK approval for lung disease drug acquired in $11 billion deal Future of Healthcategory· December 31, 2024 The U.S. Food and Drug Administration said on Friday that it has approved an ...

The next generation of the industry-proven Agilent MSD — the most popular GC/MS of all time. The 5977A MSD includes a new, highly sensitive Extractor Ion Source for higher Signal-to-Noise (SNR ...

Derived prices are not provided by exchanges. They are derived by market makers in CFD OTC market and hence prices may not be accurate and may differ from the actual market price, meaning prices ...